Premium Phosphosite-Specific 7TM Antibodies
Your Resource for GPCR Research
Select Your Country of Delivery below

Cholecystokinin Receptor 1 Antibodies

Close filters
No results were found for the filter!
NEW
Agonist-induced Serine417/Serine419 phosphorylation of CCK1 Receptor
pS417/pS419-CCK1 (phospho-Cholecystokinin...
Serine417/Serine419 (S417/S419) is a major phosphorylation site of the CCK1 receptor. The pS417/pS419-CCK1 antibody detects phosphorylation in response to high-efficacy agonists. S417/S419 phosphorylation is a key regulator of CCK1...
$ 375.00 *
NEW
Agonist-induced Serine412/Serine414 phosphorylation of CCK1 Receptor
pS412/pS414-CCK1 (phospho-Cholecystokinin...
Serine412/Serine414 (S412/S414) is a major phosphorylation site of the CCK1 receptor. The pS412/pS414-CCK1 antibody detects phosphorylation in response to high-efficacy agonists. S412/S414 phosphorylation is a key regulator of CCK1...
$ 375.00 *
NEW
Agonist-induced Threonine408/Threonine409 phosphorylation of CCK1 Receptor
pT408/pT409-CCK1 (phospho-Cholecystokinin...
Threonine408/Threonine409 (T408/T409) is a major phosphorylation site of the CCK1 receptor. The pT408/pT409-CCK1 antibody detects phosphorylation in response to high-efficacy agonists. T408/T409 phosphorylation is a key regulator of CCK1...
$ 375.00 *
Citations
Validation of the Cholecystokinin Receptor 1 in transfected HEK293 cells
CCK1 (non-phospho), Cholecystokinin Receptor 1...
The CCK1 receptor antibody is directed against the distal end of the carboxyl-terminal tail of human Cholecystokinin Receptor 1 (previously called CCKA). It can be used to detect total CCK1 receptors in Western blots independent of...
$ 375.00 *
Citations
Immunohistochemical identification of Cholecystokinin Receptor 1 in gastric mucosa.
CCK1 (IHC-grade), Cholecystokinin Receptor 1...
The CCK1 receptor antibody is directed against the distal end of the carboxyl-terminal tail of human Cholecystokinin Receptor 1 (previously called CCKA). It can be used to detect total CCK1 receptors in Western blots independent of...
$ 375.00 *

The cholecystokinin type 1 receptor (CCK₁), formerly known as CCK-A and encoded by CCKAR, is a class A G protein-coupled receptor that responds preferentially to sulfated forms of cholecystokinin (CCK). It couples predominantly to Gq/11, activating phospholipase C and increasing intracellular calcium. CCK₁ is expressed in gallbladder smooth muscle, the gastrointestinal tract, and vagal afferent neurons. Dietary fats and proteins stimulate intestinal CCK release, and activation of CCK₁ promotes gallbladder contraction and pancreatic enzyme secretion. CCK₁ signaling in vagal afferents also slows gastric emptying and contributes to meal-induced satiation. Agonist exposure can induce receptor phosphorylation, desensitization, and internalization, limiting responsiveness during sustained stimulation. The synthetic sulfated CCK octapeptide sincalide is approved in the United States for diagnostic use, including stimulation of gallbladder contraction during hepatobiliary imaging. The selective CCK₁ antagonist dexloxiglumide has been evaluated in clinical trials for irritable bowel syndrome. CCK1 receptor desensitization, β-arrestin recruitment and internalization are regulated by phosphorylation of carboxyl-terminal threonine408/threonine409 (pT408/pT409-CCK1), serine412/serine414 (pS412/pS414-CCK1) and serine417/serine419 (pS417/pS419-CCK1). This nomenclature refers to the human CCK1. This phosphorylation motif is conserved across species but corresponds to pT416-CCK1, pS420/pS422-CCK1 and pS425/pS427-CCK1 in mice. For more information on CCK1 pharmacology please refer to the IUPHAR database. For further reading refer to:

Noble F, Wank SA, Crawley JN, Bradwejn J, Seroogy KB, Hamon M, Roques BP. International Union of Pharmacology. XXI. Structure, distribution, and functions of cholecystokinin receptors. Pharmacol Rev. 1999 Dec;51(4):745-81. Erratum in: Pharmacol Rev 2000 Mar;52(1):177. PMID: 10581329.

Dufresne M, Seva C, Fourmy D. Cholecystokinin and gastrin receptors. Physiol Rev. 2006 Jul;86(3):805-47. doi: 10.1152/physrev.00014.2005. PMID: 16816139.

The cholecystokinin type 1 receptor (CCK₁), formerly known as CCK-A and encoded by CCKAR , is a class A G protein-coupled receptor that responds preferentially to sulfated forms of... read more »
Close window
Cholecystokinin Receptor 1 Antibodies

The cholecystokinin type 1 receptor (CCK₁), formerly known as CCK-A and encoded by CCKAR, is a class A G protein-coupled receptor that responds preferentially to sulfated forms of cholecystokinin (CCK). It couples predominantly to Gq/11, activating phospholipase C and increasing intracellular calcium. CCK₁ is expressed in gallbladder smooth muscle, the gastrointestinal tract, and vagal afferent neurons. Dietary fats and proteins stimulate intestinal CCK release, and activation of CCK₁ promotes gallbladder contraction and pancreatic enzyme secretion. CCK₁ signaling in vagal afferents also slows gastric emptying and contributes to meal-induced satiation. Agonist exposure can induce receptor phosphorylation, desensitization, and internalization, limiting responsiveness during sustained stimulation. The synthetic sulfated CCK octapeptide sincalide is approved in the United States for diagnostic use, including stimulation of gallbladder contraction during hepatobiliary imaging. The selective CCK₁ antagonist dexloxiglumide has been evaluated in clinical trials for irritable bowel syndrome. CCK1 receptor desensitization, β-arrestin recruitment and internalization are regulated by phosphorylation of carboxyl-terminal threonine408/threonine409 (pT408/pT409-CCK1), serine412/serine414 (pS412/pS414-CCK1) and serine417/serine419 (pS417/pS419-CCK1). This nomenclature refers to the human CCK1. This phosphorylation motif is conserved across species but corresponds to pT416-CCK1, pS420/pS422-CCK1 and pS425/pS427-CCK1 in mice. For more information on CCK1 pharmacology please refer to the IUPHAR database. For further reading refer to:

Noble F, Wank SA, Crawley JN, Bradwejn J, Seroogy KB, Hamon M, Roques BP. International Union of Pharmacology. XXI. Structure, distribution, and functions of cholecystokinin receptors. Pharmacol Rev. 1999 Dec;51(4):745-81. Erratum in: Pharmacol Rev 2000 Mar;52(1):177. PMID: 10581329.

Dufresne M, Seva C, Fourmy D. Cholecystokinin and gastrin receptors. Physiol Rev. 2006 Jul;86(3):805-47. doi: 10.1152/physrev.00014.2005. PMID: 16816139.

Recently viewed